A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 474121 in the Blood
- First Posted Date
- 2021-01-20
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 14
- Registration Number
- NCT04716894
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2021-05-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 14
- Registration Number
- NCT04714073
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany
INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation
- First Posted Date
- 2021-01-11
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 108
- Registration Number
- NCT04702893
- Locations
- 🇩🇪
Universitätsklinikum Aachen, AöR, Aachen, Germany
🇩🇪Pneumologische Praxis Dr. Löh, Bad Homburg, Germany
🇩🇪Vivantes Klinikum Neukölln, Berlin, Germany
A Study to Test Different Doses of BI 730357 and Find Out Whether They Reduce Symptoms in People With Active Psoriatic Arthritis
- First Posted Date
- 2020-12-23
- Last Posted Date
- 2021-11-08
- Lead Sponsor
- Boehringer Ingelheim
- Registration Number
- NCT04680676
A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2020-12-22
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 16
- Registration Number
- NCT04679948
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients After Switching to Tiotropium Plus Olodaterol Fixed Dose Combination in Greece
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1396
- Registration Number
- NCT04672941
- Locations
- 🇬🇷
Metropolitan Hospitsal, PNOI Pulmonology Clinic, Athens, Greece
🇬🇷European Interbalkan Medical Center, Pulmonology Clinic, Thessaloniki, Greece
A Study in Healthy Men to Test How Different Doses of BI 474121 Are Taken up and How They Influence the Amount of a Molecular Messenger (cGMP) in the Spinal Fluid
- Conditions
- Healthy
- Interventions
- Drug: PlaceboDrug: 10 milligram (mg) BI 474121Drug: 40 milligram (mg) BI 474121Drug: 2.5 milligram (mg) BI 474121Drug: 20 milligram (mg) BI 474121
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 24
- Registration Number
- NCT04672954
- Locations
- 🇳🇱
Centre Human Drug Research, Leiden, Netherlands
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight
- First Posted Date
- 2020-12-14
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 387
- Registration Number
- NCT04667377
- Locations
- 🇺🇸
Valley Weight Loss Clinic, Fargo, North Dakota, United States
🇦🇺Nepean Hospital, Kingswood, New South Wales, Australia
🇺🇸Lucas Research, Inc., Morehead City, North Carolina, United States
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 764198 Are Tolerated
- First Posted Date
- 2020-12-14
- Last Posted Date
- 2021-11-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 44
- Registration Number
- NCT04665700
- Locations
- 🇯🇵
SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku, Japan
A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 765080
- First Posted Date
- 2020-12-14
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 48
- Registration Number
- NCT04666922
- Locations
- 🇧🇪
SGS Life Science Services - Clinical Research, Edegem, Belgium